AzTrials
AzTrials

IntubationNCT01090726

Intubation With Storz Videolaryngoscope® Versus Airtraq® - in an Infant Population

A study testing Storz videolaryngoscope and Airtraq in people with Intubation and Videolaryngoscopy, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the pilot study is to compare new laryngoscopes for infants by assessing the equipment best suited to assist the intubation, with the best overview, shortest time to intubation and use these numbers to make a sample size calculation for the full protocol. Read more about this study

Who is it for?
Ages 1 month to 2 years
Conditions the study is for
Intubation, Videolaryngoscopy, Infant
What is being tested?
Storz videolaryngoscope and Airtraq
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteDenmark
Study dates
Mar 2010to Oct 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 2 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Elective surgical patients ASA-class 1-2 below the age of 2 years, with indication for intubation.
  • Informed consent from parent.
  • The parents must have legal custody of the child.
  • The parents must be able to read and understand Danish.

Who cannot join

  • Expected difficult airway.

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet

    Copenhagen, 2100

Other trials in Denmark

About this study

The purpose of the pilot study is to compare new laryngoscopes for infants by assessing the equipment best suited to assist the intubation, with the best overview, shortest time to intubation and use these numbers to make a sample size calculation for the full protocol. The investigators hypothesis is that the Storz videolaryngoscope® has a better success rate than infants (<2 years). The patients will be optimally anaesthetized with neuromuscular blockade for the intubation. All patient will be evaluated with af Macintosh blade laryngoscope, with an Airtraq® or a Storz videolaryngoscope®, and finally intubated with the other one of the later, which the patient was randomized to.

Being tested
Storz videolaryngoscope, Airtraq

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Storz videolaryngoscopeDevice

    Storz videolaryngoscope being used for the actual intubation

  • AirtraqDevice

    Airtraq being used for the actual intubation

Study groups in NCT01090726
Study groupRoleWhat they receive
Storz videolaryngoscopeExperimentalMacintosh overview followed by Airtraq overview followed by Storz videolaryngoscope overview and intubation.
Receives: Device: Storz videolaryngoscope
AirtraqActive comparatorMacintosh overview followed by Storz videolaryngoscope overview followed by Airtraq overview and intubation.
Receives: Device: Airtraq

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success rate

    Succes is defined by intubation being executed in the first try.

    Measured: 5 minutes

Secondary outcomes (6)
  1. Time to Cormack evaluation

    Measured: 5 minutes

  2. Time to intubation

    Measured: 5 minutes

  3. Number of intubation attempts

    Measured: 5 Minutes

  4. Quality of laryngeal overview before intubation

    Evaluated by Cormack score

    Measured: 5 Minutes

  5. Prevalence of post intubation stridor

    Measured: 12 hours

  6. Intubation conditions

    Measured: 5 Minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2010 (estimated)
  2. Study startMar 2010
  3. Primary completionOct 2010
  4. Study completionOct 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01090726
Sponsor's protocol ID
1A-INF-STORZ-AIR
Status last verified
Mar 2010
First submitted
18 Mar 2010
Last updated
13 Dec 2010
Results posted
No
Data monitoring committee
No

Publications

  • Lingappan K, Neveln N, Arnold JL, Fernandes CJ, Pammi M. Videolaryngoscopy versus direct laryngoscopy for tracheal intubation in neonates. Cochrane Database Syst Rev. 2023 May 12;5(5):CD009975. doi: 10.1002/14651858.CD009975.pub4.

    PubMed 37171122
  • Sorensen MK, Holm-Knudsen R. Endotracheal intubation with airtraq(R) versus storz(R) videolaryngoscope in children younger than two years - a randomized pilot-study. BMC Anesthesiol. 2012 Apr 30;12:7. doi: 10.1186/1471-2253-12-7.

    PubMed 22545575

Questions about this trial

What is this clinical trial studying?

A study testing Storz videolaryngoscope and Airtraq in people with Intubation and Videolaryngoscopy, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Dec 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success rate (time frame: 5 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01090726, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Dec 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in